US2009253201A1PendingUtilityA1

Embryonic stem cells capable of differentiating into desired cell lines

66
Assignee: DIACRIN INCPriority: Nov 3, 1993Filed: Jun 11, 2009Published: Oct 8, 2009
Est. expiryNov 3, 2013(expired)· nominal 20-yr term from priority
C12N 2501/11G01N 33/5005C12N 2506/02C12N 2501/18C07K 14/475C12N 2500/84C12N 2501/39C12N 2501/91C12N 2500/25C12N 2501/36C12N 2500/36C12N 5/0619C07K 14/715C12N 2510/00C12N 5/0068C12N 2501/395
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An embryonic stem cell which may be induced to differentiate homogeneously into a desired primary cell line. The embryonic stem cell may be engineered with DNA, which encodes a protein or polypeptide which promotes differentiation of the stem cell into a specific cell line, such as, for example, a neuronal cell line, a muscle cell line, or a hematopoietic cell line. The DNA may encode a transcription factor found in the particular cell line. In another alternative, a desired cell line is produced from embryonic stem cells by culturing embryonic stem cells under conditions which provide for a three-dimensional network of embryonic stem cells, and then stimulating embryonic stem cells with an agent, such as retinoic acid, or dimethylsulfoxide, which promotes differentiation of the embryonic stem cells into the desired cell line, such as, for example, a neuronal cell line, or a muscle cell line.

Claims

exact text as granted — not AI-modified
1 - 29 . (canceled) 
   
   
       30 . An embryonic stem cell, said embryonic stem cell having been genetically engineered with DNA which encodes MyoD, which promotes differentiation of said embryonic stem cell into a muscle cell.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.